<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>18</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>08</Month>
        <Day>17</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">In Vitro Evaluation of CMV Specific CD8+T Cells Function in CMV+ Colorectal Cancer Patients Compared to Healthy Controls</title>
    <FirstPage>379</FirstPage>
    <LastPage>392</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mona</FirstName>
        <LastName>Shaker Ardakani</LastName>
        <affiliation locale="en_US">Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Pak</LastName>
        <affiliation locale="en_US">Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran AND Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden</affiliation>
      </Author>
      <Author>
        <FirstName>Parviz</FirstName>
        <LastName>Kokhaei</LastName>
        <affiliation locale="en_US">Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran AND Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Sadegh</FirstName>
        <LastName>Fazeli</LastName>
        <affiliation locale="en_US">Department of Surgery, Imam Khomeini Complex Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Yadollah</FirstName>
        <LastName>Shakiba</LastName>
        <affiliation locale="en_US">Regenerative Medicine Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Morteza</FirstName>
        <LastName>Tabatabaei Yazdi</LastName>
        <affiliation locale="en_US">Tehran Blood Transfusion Center, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Abbasian</LastName>
        <affiliation locale="en_US">Tehran Blood Transfusion Center, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Nourizadeh</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>02</Month>
        <Day>01</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>20</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The oncogenic role of human cytomegalovirus (HCMV) has been recently shown in different cancers like colorectal cancer (CRC). According to the recent immunotherapy approach to target the CMV-expressing tumor cells, we investigated the CMV peptide-stimulated CD8+T cells functions in CRC patients compared to healthy individuals.&#xA0;All sixteen patients and seven controls were CMV seropositive. Blood samples were obtained from patients without chemotherapy and radiotherapy before surgery. Cytotoxic CD8+ T cells were generated using 14-day culture of PBMCs in the presences of CMV peptide epitopes and rhIL-2. In addition to the supernatant evaluations for TNF-&#x3B1; and IFN-&#x3B3;, the functionality of CD8+ T cells was examined by detecting CD107a and intracellular IFN-&#x3B3; using flow cytometry. CMV DNA was detected in tissues by Real Time PCR. CMV DNA was found in 31% of tumor tissues, while it was not seen in the adjacent non-tumor tissues. There was a close association between CMV in tumor tissue and tumor grade. Surface expression of CD107a and intracellular IFN-&#x3B3; in CMV-stimulated CD8+T cells and the level of IFN-&#x3B3; production in patient and control groups increased significantly after culture. The number of functions increased in patients (p&lt;0.05) and healthy individuals after culture. Followingstimulation, expressions of CD107a and intracellular IFN-&#x3B3; were elevated in tumor CMV positive patients while the TNF-&#x3B1; secretion was decreased. In vitro stimulation of PBMC in the presence of CMV peptide epitopes and IL-2 can be an applicable method to generate cytotoxic CD8+ T cells in CRC patients for future T cell therapy.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/2291</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/2291/1437</pdf_url>
  </Article>
</Articles>
